How Biotech ETFs Have Performed During the Valeant Stock Crash

Home › How Biotech ETFs Have Performed During the Valeant Stock Crash

Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. shares dropped more than 46% last week.

20.05	Eastern North Pacific Tropical Weather Outlook
20.05	Atlantic Tropical Weather Outlook
19.05	Atlantic Tropical Weather Outlook
19.05	Eastern North Pacific Tropical Weather Outlook
19.05	IT Cosmetics and Kenvue Launch New Products
19.05	Virgin Trains targets West Coast in return to rail
19.05	Cashing In On The Stache
19.05	Dr. Squatch Launches Bronco Bricc
More »

je.st